TD Cowen Maintains Buy on Boston Scientific, Raises Price Target to $100
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Joshua Jennings maintains a Buy rating on Boston Scientific and raises the price target from $86 to $100.
October 21, 2024 | 12:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
TD Cowen analyst Joshua Jennings has reaffirmed a Buy rating for Boston Scientific and increased the price target from $86 to $100, indicating confidence in the company's future performance.
The reaffirmation of a Buy rating and an increased price target from a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100